Biosimilars· May 21, 2026 · 7 min read
Herceptin biosimilars compared: FDA status, payer coverage, coding, and switching for trastuzumab
Six FDA-approved biosimilars now compete with Herceptin (trastuzumab) in oncology. This reference-product dossier maps every approved product, payer formulary...
By Ran Chen#Biosimilars#Oncology#Coverage Access